Survodutide

What it is: A dual GLP-1 and glucagon receptor agonist — boosts both appetite suppression (GLP-1) and energy expenditure (glucagon).

What it does: Expect significant weight loss with potentially better metabolic improvements than GLP-1-only drugs. Trials show fat loss, improved liver health, and stronger metabolic effects.

How it's used: Once-weekly subcutaneous injection with titration.